Skip to content
★ Sign in to follow
DO

David Owen

Abbott LaboratoriesHyperdynamics Corp
Total declarations
29
Companies
2
▲ Purchases (8 ops.)
€578k
▼ Sales (11 ops.)
€1.1M

Latest filing published 11 Mar 2013 for HYPERDYNAMICS CORP, €173k.

Insider track record

Disclosed buys
8
Disclosed sells
11
Signal history

No signal scores available.

Closed purchases

Market purchases
8
Positive at T+90
63%
Median T+90
+11.1%

Based on 8 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 11 Mar 2013 · 4991 days ago · €173k
    -61.6%
    Entry US$4.79 · Close at T+365 US$1.84
  • Filed 18 Jan 2013 · 5043 days ago · €13k
    +23.8%
    Entry US$4.83 · Close at T+365 US$5.98
  • Filed 23 May 2012 · 5283 days ago · €19k
    -41.6%
    Entry US$7.12 · Close at T+365 US$4.16
  • Filed 30 Jun 2010 · 5976 days ago · €183k
    +308.4%
    Entry US$8.56 · Close at T+365 US$34.96
  • Filed 24 May 2010 · 6013 days ago · €45k
    +348.5%
    Entry US$7.92 · Close at T+365 US$35.52

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

David Owen: trading record in brief

David Owen has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Abbott Laboratories and Hyperdynamics Corp. The record holds 29 filings, for trades running from 28 April 2006 to 7 March 2013.

The open-market side counts 8 purchases for €578k alongside 11 sales for €1.1M. On balance, insiders were net sellers of €535k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 6 share grants and 3 option exercises. In 2013 alone, the filings show 2 purchases and no sales.

The median purchase comes to €50k. For 8 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 63% of cases, with a median move of +11.1%. They describe history only and say nothing certain about the share price ahead.

On 11 March 2013 came the latest disclosure, an open-market purchase for €173k in Hyperdynamics Corp. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to David Owen

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations28 total
  • ▲
    DirectorExecutivesHyperdynamics Corp
    224,009 USD0SEC
    395,077 shares@ US$0.567Common StockSEC:0001144204-13-014181:0
    Canonical exit: 5 Jun 2013 (T+90)
  • ▲
    DirectorExecutivesHyperdynamics Corp
    17,317 USD0SEC
    29,750 shares@ US$0.5821Common StockSEC:0001144204-13-003119:0
    Canonical exit: 17 Apr 2013 (T+90)
  • ▲
    DirectorExecutivesHyperdynamics Corp
    24,318 USD0SEC
    30,740 shares@ US$0.7911Common StockSEC:0001144204-12-031432:0
    Canonical exit: 20 Aug 2012 (T+90)
  • ◆
    DirectorExecutivesAbbott Laboratories
    192,113 USD0SEC
    3,674 shares@ US$52.29Common shares without par valueSEC:0001179110-11-007243:0
  • ●
    DirectorExecutivesHyperdynamics Corp
    0SEC
    80,909 shares0Common StockSEC:0001144204-11-021665:0
  • ▲
    DirectorExecutivesHyperdynamics Corp
    224,032 USD0SEC
    207,437 shares@ US$1.08Common StockSEC:0001144204-10-035843:0
    Canonical exit: 27 Sept 2010 (T+90)
  • ▲
    DirectorExecutivesHyperdynamics Corp
    55,680 USD0SEC
    52,528 shares@ US$1.06Common StockSEC:0001144204-10-030040:0
    Canonical exit: 17 Aug 2010 (T+90)
  • ▲
    DirectorExecutivesHyperdynamics Corp
    104,160 USD0SEC
    93,000 shares@ US$1.12Common StockSEC:0001144204-10-030040:1
    Canonical exit: 17 Aug 2010 (T+90)
  • ◆
    DirectorExecutivesAbbott Laboratories
    0SEC
    2,108 shares0Common shares without par valueSEC:0001179110-10-007465:0
  • ◇
    DirectorExecutivesAbbott Laboratories
    239,972 USD0SEC
    5,616 shares@ US$42.73Common shares without par valueSEC:0001179110-10-005771:0
  • ◇
    DirectorExecutivesAbbott Laboratories
    239,974 USD0SEC
    6,413 shares@ US$37.42Common shares without par valueSEC:0001179110-10-005771:1
  • ▼
    DirectorExecutivesAbbott Laboratories
    5,444 USD0SEC
    100 shares@ US$54.44Common shares without par valueSEC:0001179110-10-005771:2
  • ▼
    DirectorExecutivesAbbott Laboratories
    540,535 USD0SEC
    9,929 shares@ US$54.44Common shares without par valueSEC:0001179110-10-005771:3
  • ▼
    DirectorExecutivesAbbott Laboratories
    103,436 USD0SEC
    1,900 shares@ US$54.44Common shares without par valueSEC:0001179110-10-005771:5
  • ◇
    DirectorExecutivesAbbott Laboratories
    179,959 USD0SEC
    5,010 shares@ US$35.92Common shares without par valueSEC:0001179110-10-003403:0
  • ▼
    DirectorExecutivesAbbott Laboratories
    151,984 USD0SEC
    2,800 shares@ US$54.28Common shares without par valueSEC:0001179110-10-003403:1
  • ▼
    DirectorExecutivesAbbott Laboratories
    97,704 USD0SEC
    1,800 shares@ US$54.28Common shares without par valueSEC:0001179110-10-003403:2
  • ▼
    DirectorExecutivesAbbott Laboratories
    5,971 USD0SEC
    110 shares@ US$54.28Common shares without par valueSEC:0001179110-10-003403:3
  • ▼
    DirectorExecutivesAbbott Laboratories
    5,428 USD0SEC
    100 shares@ US$54.28Common shares without par valueSEC:0001179110-10-003403:4
  • ▼
    DirectorExecutivesAbbott Laboratories
    10,856 USD0SEC
    200 shares@ US$54.28Common shares without par valueSEC:0001179110-10-003403:5
  • ▲
    DirectorExecutivesHyperdynamics Corp
    79,995 USD0SEC
    80,909 shares@ US$0.9887Common StockSEC:0001144204-09-064816:0
    Canonical exit: 14 Mar 2010 (T+90)
  • ▲
    DirectorExecutivesHyperdynamics Corp
    11,161 USD0SEC
    11,695 shares@ US$0.9543Common StockSEC:0001144204-09-064816:1
    Canonical exit: 14 Mar 2010 (T+90)
  • ◆
    DirectorExecutivesAbbott Laboratories
    0SEC
    2,465 shares0Common shares without par valueSEC:0001104659-09-026809:0
  • ◆
    DirectorExecutivesAbbott Laboratories
    0SEC
    1,917 shares0Common shares without par valueSEC:0001104659-08-028092:0
  • ▼
    DirectorExecutivesAbbott Laboratories
    613,436 USD0SEC
    11,318 shares@ US$54.20Common shares without par valueSEC:0001104659-08-020852:0

25 of 28 declarations